TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SEER

Seer Inc

Healthcare · Biotechnology

1.90$ +0.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow SEER
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-11,269.8% -3,175.0% -724.9% -413.9% -389.0% -330.6% -275.7%
604.3% 244.8% 40.0% 26.8% 36.7% 44.3% 44.9%
1,342.2% 1,120.1% 405.5% 229.3% 226.7% 202.2% 95.6%
1,123.3% 1,161.4% 405.5% 235.0%
828.4% 414.9% -91.7% -48.3% -17.9% -1.0% -3.6%
3,561.2% 691.2% 108.3% 69.9% 48.1% 25.7% 11.1%
-62,399.1% -5,268.0% -2,672.5% -835.7% 249.7% 472.2% 381.8%
62,359.5%
-5.2% -2.0% -0.5% -0.1% -0.1% -84.7% -63.3%
344.8%
62,354.3% 56,629.0% 1,824.1% 26.5% 3.0% -82.4% -65.6%
-11,314.7% 48,186.0% -1,573.2% -1,223.1% -136.4% 59.2% 40.5%
-14,831.0% -3,866.2% -833.1% -483.8% -437.2% -356.3% -286.9%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?